Frequently Asked Questions
Specially designed to meet the individual needs of each patient, PrTMS gently delivers personalized, repetitive magnetic pulses to 5-6 targeted areas of the brain. The pulses stimulate the brain’s neurons – rebuilding the abnormal cranial minicolumns in ASD patients and improving the brain’s executive functioning. PrTMS has shown to transform many non-verbal patients to verbal, reduces symptoms including toe walking and meltdowns … and more.
During each treatment session, an electromagnetic coil is placed near the patient’s scalp at five to six distinct locations on the head. The electromagnet painlessly delivers a magnetic pulse that stimulates the brain’s neurons, activating these areas of the brain that cause ASD.
PrTMS changes patients’ lives by:
- Potentially Transforming non-verbal patients into verbal children
- Reducing meltdowns
- Reducing destructive behaviors
- Diminishing toe walking
- Promoting social interactions and eye contact
- Fostering adaptability
- Decreasing anxiety and enhancing stress coping mechanisms
- Improving overall mood and reducing depression
- Promoting sleep
- Advancing memory and mental clarity
- Increasing attention span and focus
The treatment is administered at the NeuroHealth Center located at 1500 County Rd 517, Suite 214
Hackettstown, NJ.
While each protocol is customized for each patient, the treatment for autism usually takes 20 minutes. Most patients are treated five times a week – Monday through Friday – for six to 12 weeks.
While the treatment is pain-free, some patients experience a mild headache afterwards. The headache normally dissipates quickly.
The treatment does not cause any injury. The only side effect sometimes reported is a mild headache which subsides quickly.
A quantitative electroencephalogram (qEEG) is performed before the first treatment. After two weeks of treatment, another qEEG is performed, and the results of both are compared. If the EEG results show improvement, the patient is responding, and the treatment is working.
The first sign of improvement is often improved sleep, which can occur any time after treatment begins.
To ensure patient safety, PrTMS is not administered to patients who experienced previous seizure activity.
While PrTMS has demonstrated positive outcomes for autistic children and patients suffering from other disorders, the treatment does not claim to cure any ailment or disease.
PrTMS is FDA approved for depression and obsessive-compulsive disorder. It is administered off-label for other protocols such as autism, traumatic brain Injury, post-traumatic stress disorder, learning disorders, stroke, dementia, Parkinson’s, obsessive-compulsive disorder, hyper anxiety and other brain traumas and disorders.
The technology PrTMS is based upon was developed in 1985 and has been used for clinical research and treatment for more than 35 years.
Insurance currently covers the cost of PrTMS treatment for depression and obsessive-compulsive disorder only.
The diagnostic qEEG and initial consultation are free of charge. Each treatment costs $400, and optimal results are experienced when the patient receives five treatments per week for six to twelve weeks.
Interested families fill out a simple online application. After reviewing the borrower’s financial data, the lender designs one or more financing plans. This review process does not affect the borrower’s credit rating. Some financing options offer ways to cover the entire cost of the treatment and travel arrangements with a payback period of as much as five years.
If you are interested in financing, contact us. We will email you a link that provides access to our third-party financing company’s patient financing portal.
The Neuro Health Center partners with a third-party national travel service provider that can take care of all travel and short-term/long-term housing needs. Our partner has pre-negotiated discounted pricing with hotel chains nationwide that average 40% off standard rates.
If you are interested in travel and housing arrangements, contact us. We will email you the contact information.